Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism

BACKGROUND & AIMS: The role of solute carrier family 25 member 15 (SLC25A15), a critical component of the urea cycle, in hepatocellular carcinoma (HCC) progression remains poorly understood. This study investigated the impact of SLC25A15 on HCC progression and its mechanisms. - METHODS: We syste...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang, Qiangnu (Author) , Wei, Teng (Author) , Jin, Wen (Author) , Yan, Lesen (Author) , Shi, Lulin (Author) , Zhu, Siqi (Author) , Bai, Yu (Author) , Zeng, Yuandi (Author) , Yin, Zexin (Author) , Yang, Jilin (Author) , Zhang, Wenjian (Author) , Wu, Meilong (Author) , Zhang, Yusen (Author) , Peng, Gongze (Author) , Rössler, Stephanie (Author) , Liu, Liping (Author)
Format: Article (Journal)
Language:English
Published: 2024
In: Journal of hepatology
Year: 2024, Volume: 80, Issue: 2, Pages: 293-308
ISSN:1600-0641
DOI:10.1016/j.jhep.2023.10.024
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jhep.2023.10.024
Get full text
Author Notes:Qiangnu Zhang, Teng Wei, Wen Jin, Lesen Yan, Lulin Shi, Siqi Zhu, Yu Bai, Yuandi Zeng, Zexin Yin, Jilin Yang, Wenjian Zhang, Meilong Wu, Yusen Zhang, Gongze Peng, Stephanie Roessler, Liping Liu

MARC

LEADER 00000caa a2200000 c 4500
001 1896613551
003 DE-627
005 20241205154607.0
007 cr uuu---uuuuu
008 240726s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jhep.2023.10.024  |2 doi 
035 |a (DE-627)1896613551 
035 |a (DE-599)KXP1896613551 
035 |a (OCoLC)1475304410 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Zhang, Qiangnu  |d 1987-  |e VerfasserIn  |0 (DE-588)1195238126  |0 (DE-627)1677396733  |4 aut 
245 1 0 |a Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism  |c Qiangnu Zhang, Teng Wei, Wen Jin, Lesen Yan, Lulin Shi, Siqi Zhu, Yu Bai, Yuandi Zeng, Zexin Yin, Jilin Yang, Wenjian Zhang, Meilong Wu, Yusen Zhang, Gongze Peng, Stephanie Roessler, Liping Liu 
264 1 |c 2024 
300 |b Illustrationen 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 30. Oktober 2023 
500 |a Gesehen am 26.07.2024 
520 |a BACKGROUND & AIMS: The role of solute carrier family 25 member 15 (SLC25A15), a critical component of the urea cycle, in hepatocellular carcinoma (HCC) progression remains poorly understood. This study investigated the impact of SLC25A15 on HCC progression and its mechanisms. - METHODS: We systematically investigated the function of SLC25A15 in HCC progression using large-scale data mining and cell, animal, and organoid models. Furthermore, we analyzed its involvement in reprogramming glutamine metabolism. - RESULTS: SLC25A15 expression was significantly decreased in HCC tissues, and patients with low SLC25A15 levels had a poorer prognosis. Hypoxia-exposed HCC cells or tissues had lower SLC25A15 expression. A positive correlation between HNF4A, a transcription factor suppressed by hypoxia, and SLC25A15 was observed in both HCC tissues and cells. Modulating HNF4A levels altered SLC25A15 mRNA levels. SLC25A15 upregulated SLC1A5, increasing glutamine uptake. The reactive metabolic pathway of glutamine was increased in SLC25A15-deficient HCC cells, providing energy for HCC progression through additional lipid synthesis. Ammonia accumulation due to low SLC25A15 levels suppressed the expression of OGDHL (oxoglutarate dehydrogenase L), a switch gene that mediates SLC25A15 deficiency-induced reprogramming of glutamine metabolism. SLC25A15-deficient HCC cells were more susceptible to glutamine deprivation and glutaminase inhibitors. Intervening in glutamine metabolism increased SLC25A15-deficient HCC cells' response to anti-PD-L1 treatment. - CONCLUSION: SLC25A15 is hypoxia-responsive in HCC, and low SLC25A15 levels result in glutamine reprogramming through SLC1A5 and OGDHL regulation, promoting HCC progression and regulating cell sensitivity to anti-PD-L1. Interrupting the glutamine-derived energy supply is a potential therapeutic strategy for treating SLC25A15-deficient HCC. - IMPACT AND IMPLICATIONS: We first demonstrated the tumor suppressor role of solute carrier family 25 member 15 (SLC25A15) in hepatocellular carcinoma (HCC) and showed that its deficiency leads to reprogramming of glutamine metabolism to promote HCC development. SLC25A15 can serve as a potential biomarker to guide the development of precision therapeutic strategies aimed at targeting glutamine deprivation. Furthermore, we highlight that the use of an inhibitor of glutamine utilization can enhance the sensitivity of low SLC25A15 HCC to anti-PD-L1 therapy. 
650 4 |a Amino Acid Transport System ASC 
650 4 |a Animals 
650 4 |a Biological Transport 
650 4 |a Carcinoma, Hepatocellular 
650 4 |a Glutamine 
650 4 |a Humans 
650 4 |a Hypoxia 
650 4 |a Liver cancer 
650 4 |a Liver Neoplasms 
650 4 |a Minor Histocompatibility Antigens 
650 4 |a SLC25A15 
650 4 |a Urea cycle 
700 1 |a Wei, Teng  |e VerfasserIn  |4 aut 
700 1 |a Jin, Wen  |e VerfasserIn  |4 aut 
700 1 |a Yan, Lesen  |e VerfasserIn  |4 aut 
700 1 |a Shi, Lulin  |e VerfasserIn  |4 aut 
700 1 |a Zhu, Siqi  |e VerfasserIn  |4 aut 
700 1 |a Bai, Yu  |e VerfasserIn  |4 aut 
700 1 |a Zeng, Yuandi  |e VerfasserIn  |4 aut 
700 1 |a Yin, Zexin  |e VerfasserIn  |4 aut 
700 1 |a Yang, Jilin  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Wenjian  |e VerfasserIn  |4 aut 
700 1 |a Wu, Meilong  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Yusen  |e VerfasserIn  |4 aut 
700 1 |a Peng, Gongze  |e VerfasserIn  |4 aut 
700 1 |a Rössler, Stephanie  |e VerfasserIn  |0 (DE-588)1071122991  |0 (DE-627)825603277  |0 (DE-576)255690843  |4 aut 
700 1 |a Liu, Liping  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of hepatology  |d Amsterdam [u.a.] : Elsevier Science, 1985  |g 80(2024), 2, Seite 293-308  |h Online-Ressource  |w (DE-627)320984486  |w (DE-600)2027112-8  |w (DE-576)093888856  |x 1600-0641  |7 nnas  |a Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism 
773 1 8 |g volume:80  |g year:2024  |g number:2  |g pages:293-308  |g extent:16  |a Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism 
856 4 0 |u https://doi.org/10.1016/j.jhep.2023.10.024  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240726 
993 |a Article 
994 |a 2024 
998 |g 1071122991  |a Rössler, Stephanie  |m 1071122991:Rössler, Stephanie  |d 910000  |d 912000  |d 50000  |e 910000PR1071122991  |e 912000PR1071122991  |e 50000PR1071122991  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 15 
999 |a KXP-PPN1896613551  |e 4557355986 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1896613551"],"doi":["10.1016/j.jhep.2023.10.024"]},"recId":"1896613551","physDesc":[{"extent":"16 S.","noteIll":"Illustrationen"}],"language":["eng"],"relHost":[{"recId":"320984486","id":{"zdb":["2027112-8"],"eki":["320984486"],"issn":["1600-0641"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 18.02.2020"],"part":{"extent":"16","pages":"293-308","volume":"80","issue":"2","year":"2024","text":"80(2024), 2, Seite 293-308"},"pubHistory":["1.1985 -"],"origin":[{"dateIssuedKey":"1985","dateIssuedDisp":"1985-","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","publisher":"Elsevier Science ; Wiley-Blackwell"}],"title":[{"title_sort":"Journal of hepatology","title":"Journal of hepatology","subtitle":"official journal of the European Association for the Study of the Liver"}],"disp":"Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolismJournal of hepatology"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online verfügbar: 30. Oktober 2023","Gesehen am 26.07.2024"],"origin":[{"dateIssuedDisp":"2024","dateIssuedKey":"2024"}],"name":{"displayForm":["Qiangnu Zhang, Teng Wei, Wen Jin, Lesen Yan, Lulin Shi, Siqi Zhu, Yu Bai, Yuandi Zeng, Zexin Yin, Jilin Yang, Wenjian Zhang, Meilong Wu, Yusen Zhang, Gongze Peng, Stephanie Roessler, Liping Liu"]},"person":[{"role":"aut","roleDisplay":"VerfasserIn","family":"Zhang","display":"Zhang, Qiangnu","given":"Qiangnu"},{"display":"Wei, Teng","given":"Teng","roleDisplay":"VerfasserIn","role":"aut","family":"Wei"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Jin","display":"Jin, Wen","given":"Wen"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Yan","given":"Lesen","display":"Yan, Lesen"},{"display":"Shi, Lulin","given":"Lulin","family":"Shi","role":"aut","roleDisplay":"VerfasserIn"},{"display":"Zhu, Siqi","given":"Siqi","role":"aut","roleDisplay":"VerfasserIn","family":"Zhu"},{"given":"Yu","display":"Bai, Yu","roleDisplay":"VerfasserIn","role":"aut","family":"Bai"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Zeng","display":"Zeng, Yuandi","given":"Yuandi"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Yin","display":"Yin, Zexin","given":"Zexin"},{"given":"Jilin","display":"Yang, Jilin","role":"aut","roleDisplay":"VerfasserIn","family":"Yang"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Zhang","display":"Zhang, Wenjian","given":"Wenjian"},{"family":"Wu","roleDisplay":"VerfasserIn","role":"aut","display":"Wu, Meilong","given":"Meilong"},{"display":"Zhang, Yusen","given":"Yusen","family":"Zhang","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Peng","role":"aut","roleDisplay":"VerfasserIn","given":"Gongze","display":"Peng, Gongze"},{"given":"Stephanie","display":"Rössler, Stephanie","roleDisplay":"VerfasserIn","role":"aut","family":"Rössler"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Liu","display":"Liu, Liping","given":"Liping"}],"title":[{"title_sort":"Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism","title":"Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism"}]} 
SRT |a ZHANGQIANGDEFICIENCY2024